We show that adding Hesperetin-loaded nanoparticles to the immunoadjuvant anti-CD40 and delivery in an aerosol format is effective in treating orthotopic lung cancer in mice, even without the inclusion of radiation. Here, CD40 is linked to lung carcinoma.